Phosphagenics - Returns coming from a >$100m investment Stuart Roberts Pitt Street Research and NDF Research
Invitrocue - this Singapore company can predict cancer treatment outcomes Stuart Roberts Pitt Street Research and NDF Research
Actinogen Medical (ASX: ACW) - Breaking the long dry spell in Alzheimer’s treatment Stuart Roberts Pitt Street Research and NDF Research
Kazia Therapeutics - Picking up where Genentech left off Stuart Roberts Pitt Street Research and NDF Research
Is this the start of the Australian Life Science Boom? The Viralytics/Merck deal is telling you something... Stuart Roberts Pitt Street Research and NDF Research
AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors Stuart Roberts Pitt Street Research and NDF Research
Starpharma (ASX:SPL) - It's big business putting new life into old drugs Stuart Roberts Pitt Street Research and NDF Research
